Seattle Genetics Enterprise Value:
4.056B for May 17, 2013Seattle Genetics Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 4.056B |
| May 16, 2013 | 4.010B |
| May 15, 2013 | 4.177B |
| May 14, 2013 | 4.280B |
| May 13, 2013 | 4.132B |
| May 10, 2013 | 4.091B |
| May 9, 2013 | 3.874B |
| May 8, 2013 | 3.874B |
| May 7, 2013 | 3.900B |
| May 6, 2013 | 4.011B |
| May 3, 2013 | 4.014B |
| May 2, 2013 | 3.996B |
| May 1, 2013 | 3.914B |
| April 30, 2013 | 4.086B |
| April 29, 2013 | 4.188B |
| April 26, 2013 | 4.138B |
| April 25, 2013 | 4.129B |
| April 24, 2013 | 4.035B |
| April 23, 2013 | 4.268B |
| April 22, 2013 | 4.248B |
| April 19, 2013 | 4.087B |
| April 18, 2013 | 3.861B |
| April 17, 2013 | 3.952B |
| April 16, 2013 | 4.040B |
| April 15, 2013 | 3.878B |
| April 12, 2013 | 4.102B |
| April 11, 2013 | 4.118B |
| April 10, 2013 | 4.031B |
| April 9, 2013 | 3.828B |
| April 8, 2013 | 3.841B |
| April 5, 2013 | 3.827B |
| April 4, 2013 | 3.780B |
| April 3, 2013 | 3.734B |
| April 2, 2013 | 3.820B |
| April 1, 2013 | 3.832B |
| March 28, 2013 | 3.912B |
| March 27, 2013 | 3.971B |
| March 26, 2013 | 4.010B |
| March 25, 2013 | 3.985B |
| March 22, 2013 | 3.998B |
| March 21, 2013 | 3.825B |
| March 20, 2013 | 3.778B |
| March 19, 2013 | 3.621B |
| March 18, 2013 | 3.660B |
| March 15, 2013 | 3.676B |
| March 14, 2013 | 3.605B |
| March 13, 2013 | 3.576B |
| March 12, 2013 | 3.490B |
| March 11, 2013 | 3.414B |
| March 8, 2013 | 3.368B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
SGEN Enterprise Value Benchmarks
| Companies | |
|---|---|
| Immunogen | 1.171B |
| Immunomedics | 238.01M |
| Cleveland BioLabs | 58.95M |
SGEN Enterprise Value Rankings
| Overall |
86th percentile 1118 of 8008 |
| Sector |
86th percentile 94 of 685 in Healthcare |
| Industry |
93rd percentile 15 of 249 in Biotechnology |
SGEN Enterprise Value Range, Past 5 Years
| Minimum | 497.70M | Jun 11 2008 |
| Maximum | 4.280B | May 14 2013 |
| Average | 1.475B |
